menu
    • menu

    Company profile for Scienture

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scienture, LLC is a branded, specialty pharmaceutical company based in New York. The company focuses on developing and bringing to market unique specialty products that provide enhanced value to patients and healthcare systems. While Scienture is deeply involved in research and development, product development, and commercialization, there is no explicit information indicating that they engage in in-house pharmaceutical manufa...
    Scienture, LLC is a branded, specialty pharmaceutical company based in New York. The company focuses on developing and bringing to market unique specialty products that provide enhanced value to patients and healthcare systems. While Scienture is deeply involved in research and development, product development, and commercialization, there is no explicit information indicating that they engage in in-house pharmaceutical manufacturing. Therefore, it is likely that they collaborate with contract manufacturing organizations to produce their pharmaceutical products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ScientureUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2420 Brunello Trace Lutz , FL 34558
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://scienture.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scienture Secures $11M in Debt Financing to Fuel Growth
    Scienture Secures $11M in Debt Financing to Fuel Growth

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3289973/0/en/scienture-secures-11-0-million-in-non-dilutive-debt-financing-to-accelerate-growth-of-approved-product-portfolio-and-advancement-of-r-d-pipeline.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Scienture Granted Nasdaq Extension To Restore Bid Price
    Scienture Granted Nasdaq Extension To Restore Bid Price

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274413/0/en/Scienture-Granted-180-Day-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Scienture Annual Shareholder Update Highlights Progress
    Scienture Annual Shareholder Update Highlights Progress

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268403/0/en/Scienture-Provides-Annual-Shareholder-Update-Outlining-Significant-Progress-and-Strategic-Priorities-for-the-Year-Ahead.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    SCIENTURE Reveals 2025 Financials And Business Update
    SCIENTURE Reveals 2025 Financials And Business Update

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264594/0/en/SCIENTURE-Reports-Year-End-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Sciento Expands Rezenopy Access to 5,000 U.S. Institutions
    Sciento Expands Rezenopy Access to 5,000 U.S. Institutions

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253734/0/en/SCIENTURE-Broadens-Commercial-Access-for-REZENOPY-Highest-Dose-FDA-Approved-Naloxone-Nasal-Spray-Through-GPO-Agreements-Reaching-Over-5-000-U-S-Institutions.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Scienture Provides Commercial Update on Arbli
    Scienture Provides Commercial Update on Arbli

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231048/0/en/SCIENTURE-Provides-Commercial-Update-on-ARBLI-the-First-FDA-Approved-Ready-to-Use-Oral-Suspension-of-Losartan-Potassium.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search